Advertising Driven Press Release Distribution
Advertising Driven Press Release Distribution
InsightAce Analytic Pvt. Ltd. has announced the publication of a market research report titled “Global Animal Microbiome Market by (Product (Phage Therapy Product, Functional Food (Probiotics, Prebiotics, and Others), Sequencing Platforms, Feed Additives/Functional Ingredients, Alternative Proteins and Alternative Feed, and Other Innovative Microbiome Products and Therapies), Application (Disease Therapeutics, Diagnostics, and Nutrition), Animal Type (Poultry, Ruminants, Swine, Aquaculture, and Pets)) – Market Outlook and Industry Analysis 2030” According to company’s newest research, the global Animal Microbiome Market is worth US$ 5.75 Billion in 2021 and is predicted to reach US$ 12.4 Billion in 2030, with a promising CAGR of 9.0 % between 2022 and 2030.
Get Demo Sample copy of Animal Microbiome Market Report at: https://www.insightaceanalytic.com/request-sample/1046
Antibiotic use in animal production is intended to prevent disease, it has the unintended consequence of increasing pathogenic bacteria’ resistance to antibiotics. Antibiotic resistance is becoming more common, posing a threat to animals. Microbiome enrichment can be used as an alternative to antibiotics in the prevention of pathogen infection. A healthy microbiome can compete with harmful microorganisms and thus protect the animal from a number of infections. Providing certain dietary components to animals has the potential to modulate the microbiota and its impact on the host by limiting pathogen colonization and dissemination and lowering the risk of disease. The inclusion of pre-and probiotics to the feed as supplements can help to create a healthy microbiome. A healthy microbiome is key to having healthy livestock with fewer infections as well as optimal utilization of nutrients for weight gain and milk production.
Importance of Prebiotics and Probiotics in Animals
Prebiotics are indigestible compounds that impact the composition or activity of the gut microbiota via microbial metabolism. Wheat starch, beet pulp, inulin, and nonstarch polysaccharides such as fructo-oligosaccharides and galacto-oligosaccharides are all examples. Additionally, prebiotics protects the gut epithelium and increase the mucus layer. They may promote the growth of lactobacilli and bifidobacteria in dogs and cats while suppressing the growth of pathogens such as E Coli and Clostridium perfringens.
Probiotics are nourished in large quantities to colonise the intestine and improve or restore the microbiota. Lactobacilli and Bifidobacteria are frequently found in commercial probiotics and have been shown to reduce susceptibility to diarrhoea and respiratory tract infections. Other strains may contain Bacilli and Streptococci as well. Probiotics have also shown promising results in the treatment of inflammatory bowel disease, protein-losing enteropathy, and chronic diarrhoea.
The Growth of the animal microbiome is primarily driven by factors such as the rising demand for disease identification, treatment, and prevention in livestock and companion animals, as well as the growing pet population. The animal nutrition industry has created various opportunities for product innovation in the animal microbiome market. The Health and lifespan of animals have been related to healthy gut microbiota (the digestive system and the way it processes food for nutrition and energy). In 2018, the Association for Pet Obesity Prevention reported that 56% of dogs and 60% of cats were overweight or obese. Diarrhoea, skin, immune system, and weight problems can arise when a pet’s microbiome is out of balance and controlling unpleasant symptoms can damage a pet’s quality of life. Growing awareness about antibiotic-free animal products, rising meat consumption and augmented R&D activities to improve and modify microbiome, which is expected to further stimulate product demand in the coming years.
However, CGMs are currently relatively expensive, which could constitute a major barrier to their adoption in underdeveloped nations with high rates of prediabetes and diabetes. Furthermore, sensor life is less than two weeks, leaving room for researchers to investigate ways to extend sensor life. Development of low-cost biocompatible materials for wearables, such as paper-based materials, as well as device simplification and transducer recycling, would all help to reduce costs.
For more Customization in this Report, Connect with us at: https://www.insightaceanalytic.com/customisation/1046
The Global market is seeing mergers and acquisitions as well as strategic alliances such as investing in cutting-edge technologies to obtain significant opportunities during the forecast period.
The following key companies are engaged in the Animal Microbiome market:
Animal Biome, Inc., ANIZOME LLC, Cargill, Chr. Hansen Holding A/S, Cytophage Technologies Inc., DuPont Industrial Biosciences, Elanco Animal Health, EnBiotix, Inc., Gnubiotics Sciences SA, Hill’s Pet Nutrition, Inc., Intralytix, Koninklijke DSM N.V. (Royal DSM), Lallemand Inc., Land O’Lakes, Inc., Leiber GmbH, MicroSintesis, NomNomNow Inc., Novozymes A/S, Orion Pharma Animal Health, Phage Technologies SA, Phagelux, Inc., Phibro Animal Health Corporation, ProDigest, Tonicity International Limited, and VetoPhage.
Get Extra Discount on Animal Microbiome Market Report, if your Company is Listed in Above Key Players List @ https://www.insightaceanalytic.com/enquiry-before-buying/1046
Big Data in Healthcare Market 2022 Global Share, Trend, Segmentation and Forecast To 2030| GE Healthcare, Health Catalyst, IBM Corporation, Siemens Healthineers, Xerox Holdings Corporation, Oracle Corporation, McKesson Corporation,
Global AI-based Personalized Stylist Market worth $804.06 Million by 2030 – Exclusive Report by InsightAce Analytic
Global Live Biotherapeutic Product (LBP) Market worth $ 2.60 billion by 2030 – InsightAce Analytic
Global Smart Nebulizer Market | Key Players are Sunset Healthcare Solutions Inc., Taidoc Technology Corporation, Vapo Health, Vectura, Wuhan W.E.O. Science & Technology Development, YirDocand and other prominent players
Global Radioligand Therapy Market | Key Players are Johnson & Johnson Services, Inc., Pfizer Inc., Bayer AG, Molecular Partners, ITM Isotope Technologies Munich SE, Amneal Pharmaceuticals LLC, Novartis International AG and many more.